Latin America: Challenges & Opportunities in Clinical Research
With an established regulatory environment and a strong healthcare infrastructure, Latin America continues to grow as an advantageous landscape for conducting clinical research. Join Medpace experts Anibal Calmaggi, MD, Senior Medical Director, Infectious Diseases and Vaccines, and Wanda Dobrzanski, MD, Director Clinical Operations, Pediatric, Infectious Diseases and Pharmaceutical medicine specialist, as they share their collective 36 years of experience in designing and managing clinical research in Latin America.
This webinar discusses:
- Advantages and benefits of running trials in Latin America
- Challenges and strategies for addressing them
- Required procedures and processes
- An in-depth look at the most significant Latin American countries for conducting clinical research
Anibal Calmaggi, M.D.,
Senior Medical Director,
Infectious Diseases & Vaccines,
Dr. Anibal Calmaggi serves as a Medical Monitor for infectious diseases and vaccines at Medpace and brings more than a decade of director level clinical operations and medical affairs experience to the discussion. He has extensively participated in the elaboration and review of several clinical guidelines in practice including upper respiratory infections, hospital acquired pneumonia, and infection in recipients of hematopoietic stem cell transplants.
Wanda Dobrzanski, M.D.,
Head of Clinical Operations,
Latin Ameria, Medpace
Dr. Wanda Dobrzanski is the Head of Clinical Operations for Medpace in the Latin America region. With over 22 years of experience in designing and managing clinical trials, she has the expertise to provide critical insights regarding this topic. She has received specialty training in Pediatrics, Infectious Diseases and Vaccines, and Pharmaceutical Medicine. As a medical monitor, she oversaw a variety of Phase I-IV studies, including those involving vaccines, anti-infectives (antibacterial, antiviral, and antifungal), HIV/AIDS, and biologic agents.